Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Calcijex

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 11 USDMF, 7 CEP/COS, 3 JDMF, 2 EU WC, 5 KDMF, 6 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

132 FDF Dossiers, 35 FDA Orange Book, 55 Europe, 8 Canada, 16 Australia, 1 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG, CAPSULE;ORAL - 0.5MCG, INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 17 SPI Pharma, 8 DKSH, 3 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 7 Kirsch Pharma, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 1 CD Formulation, 1 Finar, 3 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 3 Pluviaendo, 1 Qualicaps, 19 Roquette, 4 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

35 Fillers, Diluents & Binders, 23 Parenteral, 17 Taste Masking, 16 Chewable & Orodispersible Aids, 14 Direct Compression, 12 Film Formers & Plasticizers, 10 Thickeners and Stabilizers, 10 Disintegrants & Superdisintegrants, 9 Solubilizers, 9 Topical, 8 Coating Systems & Additives, 8 Empty Capsules, 6 Co-Processed Excipients, 4 Granulation, 3 Coloring Agents, 3 Surfactant & Foaming Agents, 2 Emulsifying Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 40 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

10 APIs, 13 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	CARBOGEN AMCIS AG	Switzerland	Sungjin Exim Co., Ltd.	20210705-209-J-512	calcitriol	2021-07-05	CARBOGEN AMCIS BV	Netherlands	Nieuweweg 2a, 3901 BE Veenendal, Netherlands
29/11/2025	CordenPharma	Germany	GP Therapeutics Korea Co., Ltd.	20210429-209-J-962	calcitriol	2021-04-29	Corden Pharma Colorado, Inc.	U.S.A	2075 55th Street, Boulder, Colorado (CO) 80301, United States (USA)

Calcijex

Calcijex

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers

11 USDMF

7 CEP/COS

3 JDMF

2 EU WC

5 KDMF

6 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

132 FDF Dossiers

35 FDA Orange Book

55 Europe

8 Canada

16 Australia

1 South Africa

17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG

CAPSULE;ORAL - 0.5MCG

INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

17 SPI Pharma

8 DKSH

3 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

7 Kirsch Pharma

4 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 BASF

1 CD Formulation

1 Finar

3 Gangwal Chemicals

3 Ingredion Pharma Solutions

1 Kerry

3 Lonza Capsugel

2 Microlex e.U

3 Pluviaendo

1 Qualicaps

19 Roquette

4 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

35 Fillers, Diluents & Binders

23 Parenteral

17 Taste Masking

16 Chewable & Orodispersible Aids

14 Direct Compression

12 Film Formers & Plasticizers

10 Thickeners and Stabilizers

10 Disintegrants & Superdisintegrants

9 Solubilizers

9 Topical

8 Coating Systems & Additives

8 Empty Capsules

6 Co-Processed Excipients

4 Granulation

3 Coloring Agents

3 Surfactant & Foaming Agents

2 Emulsifying Agents

INJECTABLE;INJECTION - 0.001MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 0.002MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons